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Emergency medical applications involving blood loss frequently require donated blood to enhance 
oxygen delivery to tissues and restore blood volume in a patient. However, donated blood is in short 
supply and has complications related to type-matching and blood-transmitted diseases. These 
limitations have inspired the development of red blood cell alternatives also known as hemoglobin-
based oxygen carriers (HBOC). Naturally extracellular hemoglobins, such as that of the earthworm (LtEc), 
avoid side effects such as extravasation and systemic hypertension associated with transfusion of 
mammalian derived HBOCs due to their larger size and higher structural stability in the bloodstream. 
This work focused on surface coating LtEc with oxidized dextran (Odex), an inexpensive, biocompatible 
polysaccharide, to overcome the potential immune response in vivo. Dextran was functionalized via 
oxidation then reacted with pure LtEc protein to form Odex-LtEc. Compared to native LtEc, Odex-LtEc 
showed increased size and molecular weight. Odex-LtEc also had a higher oxygen affinity, slower oxygen 
offloading rate, and a higher rate of autoxidation. Although certain HBOC characteristics such as 
increased size are linked to higher stability, animal model trials will be necessary to determine the 
efficacy of Odex-LtEc in vivo. Reaction conditions may also be further optimized to find a suitable 





The American Red Cross estimates that 36,000 red blood cell units are required in the U.S. every day.1 
With a shelf life of 42 days and type-matching requirements, donated blood is in short supply compared 
to the demand of these patients. Blood also needs to be refrigerated, which can limit its portability to 
remote areas such as combat zones. While several generations of hemoglobin-based oxygen carriers 
(HBOCs) have used mammalian hemoglobin (Hb) as a starting point for blood substitutes, these 
products have been correlated with toxic effects in clinical trials.2 Several issues were linked to the small 
size of mammal hemoglobin, which allows it to tunnel into the endothelial lining and scavenge 
vasoregulatory molecules.3–5 Researchers have been investigating larger HBOCs to mitigate these 
effects, and several HBOCs have been developed from intermolecular binding or polymerization of 
mammal HBOCs to increase their size.6 However, the specificity of reaction conditions and large size 
distribution of product complicate the creation of these HBOCs.7 
Hemoglobins from the annelid phylum, including that of the earthworm L. terrestris (LtEc protein), have 
garnered attention as naturally large, stable oxygen-carrier proteins.8 Occurring in the coelomic fluid of 
the worm, LtEc is highly stable and less prone to dissociation and denaturation than mammalian Hbs.9 
Unlike Hbs of mammals, LtEc does not rapidly scavenge nitric oxide, a reaction linked to hypertension in 
cell-free hemoglobin transfusions. LtEc is also less prone to oxidation of the heme group than 
extracellular mammal Hb due to embedded stabilizing ions, allowing it to retain oxygen-carrying 
capability for a longer time.10 Palmer et al. have developed a scalable purification method to isolate 
ultrapure LtEc, making it more feasible to collect protein for in vivo studies and potential therapeutic 
use.11 
Although LtEc is naturally stable, studies have been performed to modify the protein. Since native LtEc is 
produced by annelids, it is quickly cleared from circulation by mammal immune systems. Conjugating 
biocompatible materials to the surface of HBOCs allows a longer transfusion half-life due to the 
camouflage provided by the material adhering to the protein. Modification of LtEc via conjugation to 
functionalized polyethylene glycol (PEG), a highly hydrophobic molecule, was shown to produce a stable 
molecule at a specific reaction ratio of PEG to LtEc.12 The PEG-LtEc also was retained longer in circulation 
than native LtEc. However, due to anti-PEG antibody creation in certain patients, alternative surface 
coatings should be investigated.13 Dextran is a polysaccharide widely used as a plasma expander and can 
be functionalized via oxidation. The resulting aldehyde groups can then be bonded to amines in protein, 
covering the surface of the protein with a dextran layer. Bovine Hb and Hb nanoparticles have been 
successfully conjugated to oxidized dextran in preliminary studies.14,15 Dextran-coated bovine Hb 
showed similar oxygen carrier properties as the unmodified Hb, with a slightly decreased autoxidation 
rate.16 Dextrans below 50 kDa MW are also correlated to a reduced rate of elimination in the body, 
which could potentially improve the half-life of the dextran conjugated HBOCs.17 The purpose of this 
work was to determine a protocol for conjugating oxidized dextran (Odex) to LtEc, forming a new HBOC. 
A successful conjugation would increase the size and molecular weight of LtEc due to the coating 
material while retaining oxygen carrier properties. To study properties of the resulting molecule 
compared to native LtEc and other modified LtEc molecules, characterization methods from the 
literature were used to study the new material. A one-pot synthesis was developed from previous 
methods for the conjugation reaction and the resulting Odex-LtEc product was analyzed to determine 






The method developed by Salva et al. produced ultrapure LtEc protein via tangential flow filtration 
(TFF).11 This protocol was used to isolate LtEc from whole worms. LtEc was concentrated to 50-70 
mg/mL in 0.1 M phosphate buffered saline (PBS, pH 7.4) and was stored at -80 °C to retain its properties 
before further steps.  
Preparation of oxidized dextran & aldehyde activity assay 
To prepare Odex, 0.36 grams of dextran (40 kDa, Millipore Sigma) was dissolved in deionized (DI) water 
to a concentration of 50 mg/mL. Sodium periodate was added at a molar ratio of 1:1 periodate to 
glucose subunit and the solution was stirred in a covered glass vial for 1 hour. Odex product was isolated 
by dialyzing the solution in a cellulose tube (8 kDa) for ~48 hours against water, then lyophilized to 
produce solid crystals.  
Aldehyde activity of the lyophilized Odex was confirmed by reaction with 2,4-Dinitrophenylhydrazine 
(DNPH).15 Odex crystals were reconstituted to 20 mg/mL in DI. From this solution, 100 µL sample were 
added to 500 µL DNPH solution (0.1 M in 70 mL ethanol, 20 mL water, and 15 mL sulfuric acid), with a 
control of 100 µL water in 500 µL DNPH solution. After centrifuging the samples at 2000g for ~3 minutes 
to sediment the yellow precipitate, the supernatant was collected. Absorbance of the supernatant at 
360 nm was determined with a UV-visible spectrophotometer (HP8452A, Olis Inc., Bogart, GA). The 
difference in DNPH between the control and sample was calculated using the extinction coefficient of 
22,000 M-1 cm-1.18 Since the reaction between DNPH and aldehydes is 1:1, the molarity of consumed 
DNPH was equal to the concentration of aldehyde groups present in the Odex sample.  
𝐴𝑙𝑑𝑒ℎ𝑦𝑑𝑒𝑠 𝑝𝑒𝑟 𝑂𝑑𝑒𝑥 =
𝐴𝑏𝑠  − 𝐴𝑏𝑠  





Where Dsample is the dilution factor of the sample in the cuvette, and MOdex (mol/L) is the molarity of the 




Figure 1: Control (L) and sample (R) in DNPH solution, before centrifugation. Yellow precipitate forms upon reaction of DNPH 
with aldehydes. 
 
Figure 2: Control (L) and sample (R) in DNPH solution after centrifugation. Absorbance measurements were taken for the 
supernatant. 
Odex-LtEc synthesis 
For each batch synthesis of Odex-LtEc, 0.36g Odex was rehydrated in PBS to 20 mg/mL. About 1.2 grams 
purified LtEc (previously frozen at -80 °C and thawed to 22 °C) were added to the Odex solution to 
achieve a ratio of ~15 Odex aldehydes to LtEc amine groups. The reaction proceeded at 22 °C for 4 hours 
with stirring. The reaction was then quenched by adding glycine (2M) at 10:1 the initial aldehyde 
concentration and sodium cyanoborohydride (100 mg/mL) at 4:1 to reduce the unstable imine bond in 
the product Odex-LtEc. Odex-LtEc was isolated via TFF with 10 volume exchanges of PBS across a 500 
kDa polysulfone TFF cartridge (Spectrum Laboratories, Rancho Dominguez, CA), then was concentrated 




Figure 3: Functionalization of dextran, synthesis of Odex-LtEc, and imine quenching 
 
Figure 4: Odex-LtEc product (4 mg/mL.) 
Characterization Studies 
Size exclusion chromatography (SEC) was performed with a High-Performance Liquid Chromatography 
system (Dionex UltiMate 3000 UHPLC/HPLC, Thermo Fisher Scientific, Waltham, MA). Samples were 
diluted to 1 mg/mL, sterilized with 0.2 µM syringe filters, and separated via a mobile phase of 50 mM 
sodium phosphate buffer (7.4 pH) on an Acclaim SEC-1000 column (4.6 by 300 mm, Thermo Fisher 
Scientific, Waltham, MA). System parameters such as flowrate (0.35 mL/min) and absorbance detection 
(280 and 413 nm) were set using Chromeleon 7 software.  
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Samples were diluted to 1 mg/mL to perform zeta potential and diameter analysis. Zeta potential was 
determined with a Zeta-Pals Analyzer (Brookhaven Instruments, Holtzville, NY) and its corresponding 
software. Hydrodynamic diameter was determined via non-linear least squares fitting of values collected 
from a BI-200SM Goniometer (90° angle, 637 nm wavelength). 
 
Figure 5: Depiction of the Odex-LtEc conjugation reaction over time. Functionalized dextran attaches to LtEc via aldehyde-
amine bonds, forming a thin layer around the protein. 
Oxygen Equilibrium Curves 
Odex-LtEc samples were diluted to 1 mg/mL (60 µM heme basis) in HEMOX buffer (TCS Scientific, New 
Hope, PA). 20 µL of Additive A, 10 µL of Additive B, and 20 µL of antifoam (TCS Scientific) were mixed 
thoroughly with the solution. Oxygen equilibrium curves were generated for the solution at 37 °C using a 
HEMOX Analyzer (TCS Scientific, New Hope, PA). Samples were bubbled with air to reach 142 mmHg 
partial oxygen pressure, then bubbled with nitrogen to deoxygenate. Absorbance readings were 
collected as the partial O2 pressure dropped. The results were fit to the Hill equation to determine the n 
and P_50 values.19 
𝑌 =
𝐴 − 𝐴





Stopped-flow Rapid Deoxygenation Kinetics 
Odex-LtEc samples were diluted to 12.5 µM heme in PBS. The deoxygenated buffer was prepared as 2 
mg/mL sodium dithionite in deionized water. Absorbance readings were taken at 437.5 nm as the 
sample was rapidly mixed with the buffer in a microvolume stopped-flow spectrophotometer (Applied 
Photophysics Ltd., Surrey, UK). The rate of rapid oxygen offloading for Odex-LtEc at ambient 
temperature (22 °C) was determined by fitting an exponential decay model to the absorbance data. 
Autoxidation Rate 
Odex-LtEc samples were diluted (60 µM heme in PBS) and held at 37 °C using a recirculating water bath. 
Absorbance spectra from 300 to 700 nm were taken with a UV-visible spectrophotometer each hour for 
24 hours. Concentrations of oxygen-carrying LtEc (oxyLtEc) and oxidized LtEc (Fe3+ state, metLtEc) were 
quantified for each time point based on spectra of the pure species for native LtEc. The relative 
remaining oxyLtEc was fitted to a first-order kinetics model to determine a rate constant for the 




4 Results & discussion 
Efficacy of synthesis protocol 
Odex reactivity after lyophilization was quantified as 75 aldehydes per Odex molecule. An excess of 
Odex was added to the native LtEc for conjugation such that the aldehyde to amine ratio was 
approximately 15:1. The Odex-LtEc had a significantly larger hydrodynamic diameter of 44 nm and 
shorter SEC elution time of 7.8 minutes, indicating a molecular weight greater than LtEc. The zeta 
potential of both native and Odex-LtEc were negative, indicating both groups would be compatible with 
the predominantly negative surface potential in the circulatory environment. A significant shift in zeta 
potential between Odex-LtEc and LtEc further suggests the surface of the protein was altered by the 
addition of Odex.  
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-30.4 ± 2.3 24.86 ± 
2.84 
2.92 ± 0.39 0.004 ± 0.001 29.19 ± 
0.04 















7.150 -12 ± 1.6 19.64 ± 
1.12 
1.43 ± 0.18 20.36 ± 0.22 0.013 ± 
0.003 





Figure 6: Hydrodynamic diameter measurements from dynamic light scattering. Odex-LtEc has a larger diameter (44 nm) 
than LtEc (28 nm). 
 
Figure 7: Elution time from a SEC column. LtEc takes longer to elute (8.1 min) than Odex-LtEc (7.8 min). 
In vitro assays and HBOC properties 
Odex-LtEc had a lower P50 and cooperativity than native LtEc at 37 °C. This aligns with prior results of 
LtEc coated with polyethylene glycol, as well as Hb conjugated to dextran.20,21 The boundary layer of the 
surface coating may act as a positive diffusive barrier, allowing the heme groups to saturate with oxygen 
at lower partial oxygen pressure. The surface coating can also restrict movement, lowering the allosteric 
effects of the multiple heme groups within a hemoglobin molecule as indicated by reduced 
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cooperativity. The greater oxygen affinity predisposes Odex-LtEc as suitable for delivering oxygen under 
hypoxia (<10 mmHg pO2).   
 
Figure 8: Oxygen binding equilibria at 37 °C fitted to the Hill equation. Cooperativity and P50 (10.8 mmHg) of Odex-LtEc are 
lower than LtEc (24.9 mmHg). 
The coefficient in the exponent term of the model fitted to the stopped-flow absorbance data 
corresponded to the oxygen offloading rate constant, koffloading (s-1). For Odex-LtEc, koffloading was 
significantly less than that of native LtEc, indicating Odex-LtEc releases oxygen more slowly. This is likely 
due to the steric hindrance of Odex polymers around the heme pockets, where oxygen binding and 
offloading take place. Note that the initial slow absorbance increase from t = 0 to 0.05 seconds (for LtEc) 
was eliminated to the curve fitting as this was observed due to the initial elimination of residual oxygen 
from the buffer and not related to the offloading reaction mechanism. Despite Odex-LtEc having a 
slower offloading rate than native LtEc, the oxygen offloading rate of LtEc is still faster than for human 
red blood cells (5 s-1), so the offloading rate is sufficient for oxygen delivery in circulation.22  
 
Figure 9: Rapid deoxygenation kinetics at 22°C. LtEc offloads oxygen at 29 s-1, while Odex-LtEc offloads oxygen at 24 s-1. 
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The autoxidation rate of native LtEc is much lower (0.004 hr-1) than human Hb (0.033 hr-1), indicating a 
greater ability for LtEc to stay in the reduced Fe2+ state at the heme iron.9 Once metHb (Fe3+) forms via 
oxidation, the Hb molecule is unable to carry oxygen. Thus, a low rate of spontaneous autoxidation is a 
desirable feature of HBOC candidates. Although Odex-LtEc showed higher rate of autoxidation at 37 °C 
than native LtEc, it not significantly different than the rate for human Hb (0.033 hr-1).12 PEG-LtEc and 
other modified HBOCs show increased autoxidation rates as well.12 Furthermore, LtEc has been stored 
for long periods of time in buffers containing certain stabilizing agents and has the potential to be 
reduced in the blood due to the presence of antioxidant species such as ascorbic acid.23,24 Since the 
autoxidation study was performed in phosphate buffered saline, none of these agents were included, 
and thus the autoxidation rate in vivo may be lower for Odex-LtEc than shown here. 
 
Figure 10: Autoxidation kinetics at 37°C. LtEc has an autoxidation rate constant of 0.004 hr-1 while the rate constant for Odex-
LtEc is approximately 0.054 hr-1.  
 
5 Conclusions & future work 
In summary, Odex-LtEc was synthesized from ultra-pure LtEc and lyophilized oxidized dextran. A one-pot 
reaction of the redissolved dextran with LtEc produced a product with a larger diameter and shorter 
elution time, indicating a significantly larger size than the native LtEc protein. The reaction protocol 
described here thus proves effective for some level of conjugation to LtEc, although modifications may 
be made in the future to pinpoint a ratio of reactants for optimal properties of the product. The oxygen-
binding P50 and cooperativity of the Odex-LtEc product was lower than the native protein. The 
autoxidation rate at 37°C was elevated and the oxygen offloading rate was lower than the native protein 
due to surface coating interactions. The differences between Odex-LtEc and native were similar to those 
observed for PEG-LtEc. The Odex-LtEc product should next be evaluated in animal models to determine 
effects in vivo. Additionally, the protocol for making the Odex-LtEc product should be evaluated at 
different ratios of Odex and reaction time to determine how these parameters affect the final product. 
Additional autoxidation studies may also be performed to more accurately mimic circulatory conditions 
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